TRUMP READIES $2.8 BILLION ISRAEL BOMB PACKAGE — 40,000 2,000-POUND BOMBS PUT U.S. TAXPAYER-FUNDED ARMS POLICY BACK AT THE CENTER OF CONGRESS
The proposed package includes 20,000 MK-84 bombs, 20,000 BLU-117 bombs and 20,000 I-2000 penetrator warheads. It has been informally notified to Congress, is not yet final, and would be financed largely through Foreign Military Financing — U.S. grant money used by Israel to buy American weapons.
WASHINGTON — The Trump administration is preparing what would be the largest single U.S. sale of 2,000-pound bombs to Israel in years, reopening one of the most contentious questions in American foreign policy: how far Washington should go in underwriting Israel's military power with public money while civilian-harm concerns remain at the center of the Gaza debate.
According to reporting first published by The Washington Post and subsequently confirmed by the Associated Press and Reuters, the proposed $2.8 billion package contains 40,000 2,000-pound bomb bodies — 20,000 MK-84s and 20,000 BLU-117s — plus 20,000 I-2000 penetrator warheads. U.S. officials familiar with the package said the transaction has been informally presented to the congressional committees that review major arms sales.
The deal is not final. That distinction matters. Informal notification is the stage at which lawmakers can ask questions, place political pressure on the administration, seek conditions, or try to slow a transfer before a formal notification starts the statutory review clock. But the scale alone has already turned the proposal into a major test of the Trump administration's Israel policy and of Congress's willingness to challenge it.
The administration's basic strategic case is familiar: Israel is a close U.S. ally facing threats from Iran and armed groups across the region, and Washington has long treated Israel's military edge as a core security interest. Critics answer that 2,000-pound bombs are among the most destructive conventional weapons commonly transferred by the United States and that their use in densely populated areas has repeatedly raised questions about proportionality, civilian casualties and American responsibility for the consequences.
This is therefore not merely another arms-sale number. It is a debate about alliance commitments, battlefield capability, congressional oversight, taxpayer financing and the political cost of supplying weapons whose effects are impossible to separate from the wars in which they are used.
THE PACKAGE IS BIG — AND THE WORD 'SALE' HIDES HOW IT IS PAID FOR
The headline number is $2.8 billion, but the financing mechanism is just as important as the weapons list. Most of the package is expected to be paid for through Foreign Military Financing, or FMF. Under that system, Congress appropriates U.S. funds that are provided to partner governments and then used to purchase American defense articles, services and training.
In other words, this is not simply Israel writing a $2.8 billion check to American manufacturers from its own treasury. A large share would be backed by U.S. public funds already appropriated for security assistance. Israel has long been the largest recipient of American FMF assistance. Under the current ten-year U.S.-Israel security memorandum, Washington provides $3.3 billion annually in FMF and another $500 million a year for cooperative missile-defense programs through fiscal year 2028.
That is why the phrase 'taxpayer-funded' is politically potent but needs precision. The proposal does not necessarily represent a brand-new $2.8 billion emergency appropriation created for this one transaction. Rather, it would draw largely on a standing security-assistance structure in which U.S. grants finance Israeli purchases from the American defense sector. The policy question is whether that long-established structure should continue to support transfers of this size and type under current battlefield conditions.
For supporters, FMF binds an ally to U.S. systems, strengthens interoperability, supports American defense manufacturing and gives Washington leverage through training, sustainment and end-use rules. For critics, the arrangement means American taxpayers are not distant spectators: they are helping finance weapons that may later be used in conflicts that generate humanitarian and diplomatic blowback for the United States itself.
WHAT 40,000 TWO-THOUSAND-POUND BOMBS MEANS
The MK-84 is a 2,000-pound general-purpose bomb body and one of the largest standard conventional bombs in the U.S. inventory. It can be used as an unguided munition or paired with guidance kits in precision-strike configurations. The BLU-117 is a closely related 2,000-pound bomb body designed with thermal protection for safer storage and handling, including in naval environments.
The proposed package also includes 20,000 I-2000 penetrator warheads. Those weapons are designed for hardened or deeply buried targets, allowing an attacking force to strike fortified structures that ordinary blast-fragmentation bombs may not defeat as effectively.
The attraction for Israel is straightforward. These munitions provide a large reserve of heavy strike capacity for targets ranging from fortified command sites and weapons storage areas to deeply protected military infrastructure. In a region where Israel faces the possibility of renewed fighting across multiple fronts, stockpile depth can itself be treated as deterrence.
But the same size that makes these bombs useful against hard targets is exactly what makes them controversial in urban warfare. A 2,000-pound bomb can generate a massive blast wave, throw lethal fragments over a wide area, destroy heavy structures and produce large craters. Human-rights groups and military-law specialists have repeatedly argued that using such weapons in densely populated areas creates an exceptionally high risk of civilian harm, even when the intended target is military.
Israel says its operations are directed against Hamas, Hezbollah and other armed groups and that it takes measures to reduce civilian casualties. Critics argue that the pattern of destruction in Gaza demonstrates why heavy munitions require far tighter restrictions. The new sale lands directly in the middle of that unresolved argument.
THE BIDEN PAUSE THAT TRUMP REVERSED
The controversy is sharpened by recent history. In May 2024, the Biden administration paused one shipment to Israel that included roughly 1,800 2,000-pound bombs and 1,700 500-pound bombs. Officials said the decision reflected concern about a major Israeli operation in Rafah, where more than a million displaced Palestinians had been sheltering.
That pause did not end U.S. military support for Israel. Defensive systems and many other weapons transfers continued. But it was symbolically important because it showed a U.S. president using the delivery of heavy offensive munitions as leverage over battlefield tactics.
Donald Trump reversed that policy after returning to office. His administration has consistently argued for fewer restrictions on Israel's access to U.S. weaponry and has moved quickly to approve or advance major packages. The new proposal would go far beyond the size of the shipment Biden paused, turning what was once a dispute over fewer than two thousand 2,000-pound bombs into a proposal involving forty thousand of them.
That comparison is why the package is being read as more than replenishment. It is also a statement about presidential philosophy. Biden's pause treated the munitions as leverage. Trump's approach treats large-scale supply as an expression of strategic commitment.
THIS WOULD NOT BE THE FIRST HUGE PACKAGE
The Trump administration already used emergency authority in February 2025 to approve a separate $2.04 billion sale to Israel involving 35,529 MK-84 or BLU-117 bomb bodies, or a combination of the two, along with 4,000 I-2000 penetrator warheads and related support.
The Defense Security Cooperation Agency said at the time that the Secretary of State had determined an emergency existed in the national security interests of the United States and therefore waived the normal congressional review requirements. Deliveries from that sale were expected to begin in 2026.
That earlier package provides important context. The proposed 2026 sale is not appearing in a vacuum. It would build on a continuing pipeline of heavy munitions and increase the scale substantially. It also explains why lawmakers are watching the current process closely: an informal notification suggests Congress has a window to raise objections before the administration completes formal approval, unless the executive branch again chooses to invoke emergency authority.
The administration has not publicly said that it intends to bypass Congress this time. A senior administration official, asked about the pending transaction, said foreign arms sales were moving through the appropriate process and declined to comment on a sale that had not yet been finalized.
CONGRESS NOW HAS A REAL FIGHT IN FRONT OF IT
Under the Arms Export Control Act, major Foreign Military Sales above statutory thresholds must be notified to Congress. For Israel, formal notification generally triggers a 15-day review period. Before that formal step, however, the State Department has long used an informal or 'tiered' review process with the Senate Foreign Relations Committee and the House Foreign Affairs Committee.
That is where the $2.8 billion package now sits, according to officials familiar with the proposal. Informal review matters because it gives committee leaders and staff a chance to demand information, raise policy objections and negotiate with the administration before the sale becomes public and the formal clock starts running.
Congress can ultimately try to block a sale through a joint resolution of disapproval, although doing so over a president's objections is politically difficult. The more immediate question is whether lawmakers can build enough pressure to delay the transaction, alter its terms, impose conditions on the use of the weapons or force the administration to defend the package publicly.
Sen. Chris Van Hollen of Maryland has already said he intends to organize opposition, arguing that sending taxpayer-financed bombs to the Netanyahu government while Gaza and Lebanon remain under attack is inconsistent with an 'America First' approach. Republicans, by contrast, remain broadly more supportive of military assistance to Israel, although some conservative media figures and voters have become more skeptical of open-ended U.S. aid abroad.
That means the sale could expose a political split that no longer follows the old, simple partisan map. Democratic support for Israel has fallen sharply since the Gaza war began, while a smaller but visible faction on the right questions why U.S. tax dollars should subsidize foreign wars at all. The administration will likely have votes on its side. The debate, however, is becoming harder to contain.
THE CIVILIAN-HARM QUESTION WILL DEFINE THE DEBATE
The central humanitarian argument is not that a 2,000-pound bomb is inherently unlawful. Large conventional weapons can be used lawfully against legitimate military targets. The legal and moral controversy turns on how, where and against what targets they are used — particularly in densely populated areas where blast and fragmentation effects are difficult to contain.
Israel has used 2,000-pound bombs in Gaza and Lebanon. Rights groups, international officials and some U.S. lawmakers have pointed to incidents involving extensive civilian casualties and destruction, arguing that the weapon's effects make it unsuitable for many urban targets. Israel rejects claims that it deliberately targets civilians and says Hamas and other armed groups operate from civilian areas, complicating efforts to distinguish combatants from noncombatants.
The Biden administration's 2024 pause was built around precisely this concern. It did not argue that Israel could never possess heavy bombs. It argued that Washington had to consider how they might be used in Rafah. The Trump administration is now signaling a much more permissive standard, and critics will inevitably ask what safeguards — if any — accompany a package twenty times larger than the shipment Biden held back.
Supporters will answer that restricting Israel's access to heavy munitions does not end the wars or eliminate civilian harm; it may instead reduce Israel's ability to strike hardened targets or deter adversaries. That is the strategic counterargument Congress will have to weigh against the humanitarian record.
THE TAXPAYER ARGUMENT IS ABOUT MORE THAN $2.8 BILLION
For Americans, the politically explosive phrase is 'U.S. taxpayer dollars.' It converts a distant foreign-policy decision into a domestic budget question. Voters may reasonably ask why federal money is helping finance tens of thousands of heavy bombs for a foreign military when the United States faces unresolved needs in infrastructure, health care, disaster recovery, veterans' services and debt reduction.
Supporters of FMF respond that foreign assistance is a small share of overall federal spending and that much of the money ultimately returns to the U.S. economy through contracts with American manufacturers. They also argue that helping allies deter wars can be cheaper than responding after regional conflicts expand and directly threaten U.S. forces or interests.
Both claims can be true at once: the program can support U.S. industry and still represent a real allocation of public resources. The key question is not whether taxpayer money is involved — it is — but whether the strategic return justifies the cost and the political consequences.
That debate will be especially sharp because the administration has framed much of its foreign policy around an 'America First' standard. Critics will argue that a taxpayer-financed bomb package for Israel must therefore pass a demanding test: how specifically does it make Americans safer, and what conditions protect the United States from being associated with misuse? Supporters will argue that a heavily armed Israel constrains Iran and allied militant groups, reducing threats to American interests across the Middle East.
WHY THE SALE MATTERS BEYOND GAZA
The strategic context is larger than one battlefield. Israel's security planners are looking at Iran, Hezbollah in Lebanon, armed groups in Syria and Iraq, and the possibility of renewed regional escalation. Heavy strike weapons are central to Israel's ability to attack fortified launch sites, underground facilities and military infrastructure.
For Washington, supporting that capability has long been part of a broader strategy of maintaining Israel's qualitative military edge. U.S. officials have traditionally argued that a militarily strong Israel deters adversaries, reduces the likelihood that enemies will attempt conventional war, and gives Washington a capable regional partner.
But arms transfers also affect U.S. diplomacy. Every large package can strengthen deterrence while simultaneously making it harder for Washington to persuade Arab governments, European allies and humanitarian organizations that the United States is a neutral broker when trying to de-escalate fighting. Weapons policy and diplomacy cannot be separated when the weapons are highly visible on the battlefield.
That tension is particularly acute now because public support for Israel in the United States has become more polarized. Reuters reported that a June Quinnipiac poll found 48 percent of U.S. voters believed Washington was too supportive of Israel, including 66 percent of Democrats. Whatever happens to the sale, the political environment around it is no longer the one that existed before October 2023.
WHAT IS CONFIRMED — AND WHAT IS NOT
Several facts are clear. The Trump administration is preparing a $2.8 billion munitions package for Israel. Officials say it includes 20,000 MK-84 bombs, 20,000 BLU-117 bombs and 20,000 I-2000 penetrator warheads. The package has been informally communicated to the congressional committees that review major arms transfers. Most of the cost is expected to be covered through Foreign Military Financing.
Other points remain unresolved. The package is not yet final. The State Department has not issued the public major-arms-sale notification that normally follows formal approval. Delivery schedules have not been publicly detailed. The administration has not announced any new restrictions governing where the munitions can be used, nor has it publicly said it will invoke emergency authority to skip the normal review process.
Those uncertainties matter because the political story is moving faster than the legal process. Headlines may describe a 'sale' as though forty thousand bombs are already on aircraft bound for Israel. That is not what has been established. The proposal is advanced enough to be before congressional reviewers, but the final approval, contractual steps and deliveries are separate stages.
The next concrete signal will be formal notification — or an administration decision to use emergency authority. Either move would tell Congress and the public how aggressively the White House intends to push the package forward.
THE REAL TEST IS WHETHER OVERSIGHT CHANGES THE OUTCOME
For decades, major U.S. arms sales to Israel have usually survived congressional scrutiny. The political alliance is deep, the security relationship is institutionalized, and presidents of both parties have treated military assistance as a strategic commitment rather than a favor that changes with each election.
What has changed is the level of public scrutiny around the weapons themselves. A 2,000-pound bomb is no longer an abstract item buried in a defense notification. It is a recognizable symbol of the destruction seen in Gaza, and that image has entered American politics.
The administration will argue that Israel must be able to replenish its stocks and defend itself in a dangerous region. Opponents will argue that Washington cannot separate support for Israel's security from responsibility for how U.S.-financed weapons are used. Congress is the institution designed to force those competing claims into the same room.
If lawmakers approve the package without conditions, the message will be that the strategic relationship still outweighs the humanitarian and political backlash. If they delay, condition or block it, that would mark a significant shift in the balance of power over U.S.-Israel arms policy.
Either way, the scale of the proposal guarantees that this will not be treated as routine paperwork. Forty thousand 2,000-pound bombs, twenty thousand penetrator warheads and $2.8 billion in largely taxpayer-financed purchasing power make the package too large — militarily, politically and symbolically — to pass unnoticed.
THE BOTTOM LINE
The Trump administration's proposed package is a clear statement that it intends to maintain, and potentially deepen, Israel's access to the heaviest conventional U.S. munitions even as civilian-harm concerns remain unresolved. But it is still a proposal moving through the arms-sale process, not a completed transfer.
The policy case for the sale rests on deterrence, alliance commitments and Israel's need to strike hardened military targets. The case against it rests on the record of heavy-bomb use in densely populated areas, the scale of U.S. taxpayer financing and the risk that Washington becomes more closely associated with future civilian casualties.
May you like
Those are not questions a headline can settle. They are precisely the questions Congress is supposed to test before the package becomes an irreversible contract.
For now, one fact towers above the rest: the United States is considering financing an enormous new stockpile of heavy bombs for Israel, and the decision will force Washington to define what 'support for an ally' means when the weapons involved are powerful enough to shape not only battlefields, but America's own political and moral debate.
